Daniel Alexander QCHe has been lead counsel in a number of defining cases in electronics, pharmaceuticals, biophysics and biotechnology, as well as some of the leading trade mark and media disputes. Daniel has a broad practice, focussing on intellectual property but extending to contractual cases, IT, media/entertainment law and a range of international disputes. He is rated […]
Martin Howe QCMartin has a particular expertise in heavy technological cases, such as the internet, computers and IT, broadcasting and telecommunications technology, and biotech and pharmaceuticals: for details of his cases in these fields, see sections on Patents and on Copyright. He has successfully concluded the major action Glaxo v Sandoz which involved two hearings in the […]
Michael Tappin QCHe is widely acclaimed for his technical abilities and legal analysis, as well as for his advocacy skills and paperwork. He has appeared in many of the leading patent cases of the past 15 years and regularly handles cases in the chemical, pharmaceutical and biotech fields, as well as in engineering and telecoms.
Adrian Speck QCHis clients vary from large biotechnology and pharmaceutical corporations, telecoms manufacturers, substantial brand owners, broadcasters, publishers, television production companies and record companies to small businesses and private authors inventors and composers.
Andrew Lykiardopoulos QCAndrew has been involved in some of the leading recent IP cases including Unwired Planet v Huawei (FRAND), the Abbvie litigation (Arrow declarations), Idenix v. Gilead (priority), Assos v ASOS (own name defence), NLA v Meltwater (copyright) and Servier v Apotex (Illegality defence). Legal 500 called him a “go-to choice for high value cases”. Andrew […]